Related Experiment Video
Updated: May 20, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Neonatal morbidities and developmental delay in moderately preterm-born children
Jorien M Kerstjens1, Inger F Bocca-Tjeertes, Andrea F de Winter
1Division of Neonatology, Beatrix Children's Hospital, University Medical Center, University of Groningen, Groningen, Netherlands. j.m.kerstjens@umcg.nl
Insights
Hypoglycemia in moderately preterm infants significantly increases the risk of developmental delays. Preventing low blood sugar in these children may improve their preschool development outcomes.
Area of Science:
- Neonatalogy
- Developmental Pediatrics
- Public Health
Background:
- Moderately preterm infants (32-35 weeks' gestation) face higher risks of neonatal issues and developmental delays.
- The specific impact of neonatal morbidities on later developmental outcomes remains unclear.
Purpose of the Study:
- To investigate the effect of neonatal morbidities in moderately preterm children on their development at preschool age.
- To identify specific neonatal conditions that contribute to developmental delays in this vulnerable population.
Main Methods:
- A community-based cohort of 832 moderately preterm children (born 2002-2003) was studied.
- Developmental outcomes were assessed at 43-49 months using the Ages and Stage Questionnaire.
- Neonatal data, including Apgar scores, asphyxia, NICU admissions, and metabolic conditions like hypoglycemia and hyperbilirubinemia, were extracted from medical records.
Main Results:
- Hypoglycemia (low blood sugar) and asphyxia were significantly associated with developmental delay.
- Tertiary NICU admission and hyperbilirubinemia showed borderline nonsignificant associations.
- In multivariate analysis, only hypoglycemia remained a significant predictor of developmental delay (OR: 2.19).
Conclusions:
- Hypoglycemia is the primary neonatal morbidity linked to increased risk of developmental delay in moderately preterm children.
- Preventive strategies targeting hypoglycemia could potentially improve developmental trajectories for these infants.
Background And Objective:
Children born moderately preterm (32-35(6/7) weeks' gestation) are at increased risk of both neonatal morbidities and developmental delays in early childhood. It is unknown whether neonatal morbidities contribute to the increased risk of developmental delay. The objective of this study was to determine the effect of neonatal morbidities after moderately preterm birth on development at preschool age.
Methods:
In a community-based, stratified cohort, parents of 832 moderately preterm children born in 2002 or 2003 completed the Ages and Stage Questionnaire when their child was 43 to 49 months old. Data on Apgar scores, asphyxia, tertiary NICU admission, hospital transfer, circulatory insufficiency, hypoglycemia, septicemia, mechanical ventilation, continuous positive airway pressure, apneas, caffeine treatment, and hyperbilirubinemia were obtained from medical records. We assessed associations of neonatal characteristics with developmental delay, adjusted for gender, small-for-gestational-age status, gestational age, and maternal education.
Results:
Hypoglycemia and asphyxia were associated with developmental delay; odds ratios (ORs) were 2.42 (95% confidence interval [CI]: 1.23-4.77) and 3.18 (95% CI: 1.01-10.0), respectively. Tertiary NICU admission and hyperbilirubinemia had positive but statistically borderline nonsignificant associations with developmental delay: ORs were 1.74 (95% CI: 0.96-3.15) and 1.52 (95% CI: 0.94-2.46), respectively. No other neonatal morbidities were associated with developmental delay. In multivariate analyses, only hypoglycemia was associated with developmental delay (OR: 2.19; 95% CI: 1.08-4.46).
Conclusions:
In moderately preterm-born children, only hypoglycemia increased the risk of developmental delay at preschool age. A concerted effort to prevent hypoglycemia might enhance developmental outcome in this group.
Related Concept Videos
Teratogenicity
Development of the Oral Microbiota
Neurulation
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

